Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
This study is ongoing, but not recruiting participants.
Study NCT00005049 Information provided by National Cancer Institute (NCI)
First Received: April 6, 2000 Last Updated: July 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Gastric Cancer
Gastrointestinal Carcinoid Tumor
Gastrointestinal Stromal Tumor
Ovarian Cancer
Peritoneal Cavity Cancer
Small Intestine Cancer
Additional conditions recognized in this trial
Carcinoid Tumor
Colorectal Neoplasms
Duodenal Neoplasms
Gastrointestinal Neoplasms
Gastrointestinal Stromal Tumors
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Malignant Carcinoid Syndrome
Ovarian Neoplasms
Peritoneal Neoplasms
Stomach Neoplasms
More general conditions related to this trial
Abdominal Neoplasms
Adenocarcinoma
Adnexal Diseases
Carcinoma
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Duodenal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Ileal Diseases
Intestinal Diseases
Jejunal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Ovarian Diseases
Peritoneal Diseases
Rectal Diseases
Stomach Diseases
Urogenital Neoplasms
Interventions listed in this trial
carboplatin
cisplatin
floxuridine
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
New York University School of Medicine
National Cancer Institute (NCI)
Back to top of Main Content
